Surgical Outcomes for Retroperitoneal Liposarcomas in an Asian Center
Author Information
Author(s): Lee Ser Yee, Goh Brian Kim Poh, Teo Melissa Ching Ching, Chew Min Hoe, Chow Pierce Kah Hoe, Wong Wai Keong, Ooi London LPJ, Soo Khee Chee
Primary Institution: Singapore General Hospital
Hypothesis
What are the clinical results and prognostic factors for retroperitoneal liposarcomas in an Asian population?
Conclusion
An aggressive surgical approach for retroperitoneal liposarcomas is associated with 3- and 5-year survival rates of 87% and 49%, respectively.
Supporting Evidence
- Median disease-free survival was 19 months.
- Overall 3-year survival rate was 87%.
- Overall 5-year survival rate was 49%.
- Contiguous organ resection was required in 71.4% of patients.
Takeaway
Doctors looked at 21 patients with a type of tumor called liposarcoma and found that surgery can help many of them live longer, even if the tumors are big.
Methodology
A retrospective review of patients with primary retroperitoneal liposarcoma treated between June 1990 and June 2005.
Potential Biases
The retrospective nature of the study may introduce bias.
Limitations
The study is retrospective and has a small sample size, which may lead to Type II errors.
Participant Demographics
12 males and 9 females, mean age 52.4 years.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website